Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 10, 2019
MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative
Kelsey R Thomas, Emily C Edmonds, Joel S Eppig, et al.
American Journal of Human Genetics
|
October 16, 2004
A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening
Regina Ensenauer, Jerry Vockley, Jan-Marie Willard, et al.
Dementia and Geriatric Cognitive Disorders
|
November 5, 2018
Neuropsychological Criteria for Mild Cognitive Impairment in the Framingham Heart Study's Old-Old
Christina G Wong, Kelsey R Thomas, Emily C Edmonds, et al.
Neurology
|
February 19, 2016
Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies
Lon R White, Steven D Edland, Laura S Hemmy, et al.
Journal of Alzheimer'S Disease : JAD
|
October 6, 2011
Imaging the Alzheimer brain
J Wesson Ashford, Ahmad Salehi, Ansgar Furst, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 30, 2021
Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report
Greg A Jicha, Erin L Abner, Steven E Arnold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Howard H Feldman, Karen Messer, Jing Zhang, et al.
Acta Neuropathologica
|
November 2, 2019
Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions
Patricia Aguilar-Calvo, Alejandro M Sevillano, Jaidev Bapat, et al.
Plos One
|
May 29, 2024
Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam)
Howard H Feldman, José A Luchsinger, Gabriel C Léger, et al.
Brain : a Journal of Neurology
|
December 17, 2021
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
Allan I Levey, Deqiang Qiu, Liping Zhao, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 10, 2019
MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative
Kelsey R Thomas, Emily C Edmonds, Joel S Eppig, et al.
American Journal of Human Genetics
|
October 16, 2004
A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening
Regina Ensenauer, Jerry Vockley, Jan-Marie Willard, et al.
Dementia and Geriatric Cognitive Disorders
|
November 5, 2018
Neuropsychological Criteria for Mild Cognitive Impairment in the Framingham Heart Study's Old-Old
Christina G Wong, Kelsey R Thomas, Emily C Edmonds, et al.
Neurology
|
February 19, 2016
Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies
Lon R White, Steven D Edland, Laura S Hemmy, et al.
Journal of Alzheimer'S Disease : JAD
|
October 6, 2011
Imaging the Alzheimer brain
J Wesson Ashford, Ahmad Salehi, Ansgar Furst, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 30, 2021
Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report
Greg A Jicha, Erin L Abner, Steven E Arnold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Howard H Feldman, Karen Messer, Jing Zhang, et al.
Acta Neuropathologica
|
November 2, 2019
Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions
Patricia Aguilar-Calvo, Alejandro M Sevillano, Jaidev Bapat, et al.
Plos One
|
May 29, 2024
Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam)
Howard H Feldman, José A Luchsinger, Gabriel C Léger, et al.
Brain : a Journal of Neurology
|
December 17, 2021
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
Allan I Levey, Deqiang Qiu, Liping Zhao, et al.
Page
of 10